Managed Health Care Connect February 14, 2018
David Costill

A new perspective in the New England Journal of Medicine outlines how the recent deal between CVS and Aetna will change health care in ways that previous mergers have not.

Leemore S Dafny, PhD, of the department of general management at the Harvard Business School, explained in her perspective that the CVS/Aetna deal is the largest the health care industry has ever seen outside of pharma company mergers. She also explained that unlike previous mega-mergers, the CVS/Aetna deal will change health care in unique ways.

“The proposed CVS–Aetna merger is largely “vertical,” involving consolidation “up and down” the value chain,” she wrote. “Vertical mergers enable myriad channels that can actually heighten competition, although there is still a risk that competition...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Healthcare System, Mergers & Acquisitions / JV, Payer, Pharma, Retail care
Boston Scientific to buy Intera Oncology, maker of liver cancer treatment
Halozyme abandons its €2bn pursuit of Evotec
M&A Cyber Success Depends on Communication, an Honest Evaluation of Each Side’s Strengths & Risks, and an Open Mind
Halozyme Pulls €2B Acquisition Bid as Evotec Commits to Standalone Strategy
Weekly HCRE Briefing: AdventHealth to Acquire Two CHS Hospitals in FL | Kaiser Acquiring ASCs and MOBs

Share This Article